Reprogrammed metabolism of cancer cells as a potential therapeutic target

Curr Pharm Des. 2014;20(15):2580-94. doi: 10.2174/13816128113199990483.

Abstract

Metabolism in cancer cells is reprogrammed. Cancer cells largely depend on glycolysis for ATP production. The metabolic alterations in cancer cells facilitate resistance to cell death as well as biosynthesis of nucleotides and lipids, building blocks for growth. The reprogrammed metabolism is increasingly seen as a target in cancer therapy. This review describes the metabolic reprogramming of cancer cells and illustrates how this is related to cell cycle and apoptosis resistance. Is also describes various scenarios for targeting cancer cell metabolism and highlights options for interventions with nutrition and bioactive food components.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AMP-Activated Protein Kinases / physiology
  • Amino Acids / metabolism
  • Animals
  • Apoptosis
  • Glycolysis
  • Humans
  • Mitochondria / metabolism
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Nucleotides / biosynthesis
  • Oxidative Phosphorylation
  • Reactive Oxygen Species / metabolism

Substances

  • Amino Acids
  • Nucleotides
  • Reactive Oxygen Species
  • AMP-Activated Protein Kinases